Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

被引：0
|
作者：
Katerina Chatzidionysiou
Elisabeth Lie
Evgeny Nasonov
Galina Lukina
Merete Lund Hetland
Ulrik Tarp
Ioan Ancuta
Karel Pavelka
Dan C. Nordström
Cem Gabay
Helene Canhão
Matija Tomsic
Piet L. C. M. van Riel
Juan Gomez-Reino
Tore K. Kvien
Ronald F. van Vollenhoven
机构：
[1] Karolinska Universitetssjukhustet,Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00
[2] Diakonhjemmet Hospital,Department of Rheumatology
[3] ARBITER,DANBIO, Department of Rheumatology
[4] Institute of Rheumatology,Department of Rheumatology
[5] Copenhagen University Hospital at Glostrup,undefined
[6] Aarhus University Hospital,undefined
[7] Cantacuzino Hospital,undefined
[8] Charles University,undefined
[9] ROB-FIN Helsinki University Central Hospital,undefined
[10] SCQM registry,undefined
[11] University Hospital of Geneva,undefined
[12] Rheumatic Diseases Portuguese Register,undefined
[13] Rheumatology Research Unit,undefined
[14] Instituto de Medicina Molecular,undefined
[15] University Medical Center,undefined
[16] Radboud University Nijmegen Medical Centre,undefined
[17] Hospital Clinico Universitet De Santiago,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Rituximab; Rheumatoid arthritis; Observational;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration
    Chatzidionysiou, Katerina
    Lie, Elisabeth
    Nasonov, Evgeny
    Lukina, Galina
    Hetland, Merete Lund
    Tarp, Ulrik
    van Riel, Piet L. C. M.
    Nordstrom, Dan C.
    Gomez-Reino, Juan
    Pavelka, Karel
    Tomsic, Matija
    Kvien, Tore K.
    van Vollenhoven, Ronald F.
    Gabay, Cem
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 374 - 377
  • [42] Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10)
    Ekin, Ali
    Misirci, Salim
    Lermi, Nihal
    Kutlu, Nagehan Dik
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Dalkilic, Ediz
    Pehlivan, Yavuz
    AKTUELLE RHEUMATOLOGIE, 2025, 50 (01) : 71 - 82
  • [43] Smoking and Response to Rituximab in Anti-CCP Positive and Negative Rheumatoid Arthritis - Results from an International European Collaboration.
    Chatzidionysiou, Katerina
    Lie, Elisabeth
    Nasonov, Evgeny
    Lukina, Galina
    Hetland, Merete Lund
    Hauge, Ellen
    Pavelka, Karel
    Gabay, Cem
    Nordstrom, Dan
    Canhao, Helena
    Tomsic, Matija
    van Riel, Piet
    Gomez-Reino, Juan J.
    Ancuta, Ioan
    Kvien, Tore K.
    van Vollenhoven, Ronald F.
    Saevarsdottir, Saedis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1104 - S1104
  • [44] COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    Bynum, L. A.
    Joshi, N.
    VALUE IN HEALTH, 2010, 13 (03) : A126 - A126
  • [45] Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
    Koehm, Michaela
    Foldenauer, Ann C.
    Rossmanith, Tanja
    Alten, Rieke
    Aringer, Martin
    Backhaus, Marina
    Burmester, Gerd R.
    Feist, Eugen
    Kellner, Herbert
    Krueger, Klaus
    Mueller-Ladner, Ulf
    Rubbert-Roth, Andrea
    Tony, Hans-Peter
    Wassenberg, Siegfried
    Burkhardt, Harald
    Behrens, Frank
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [46] Opportunistic Infections in Patients with Rheumatoid Arthritis Treated with Rituximab: Data From the Autoimmunity and Rituximab Registry
    Gottenberg, Jacques-Eric
    Ravaud, Philippe
    Bardin, Thomas
    Cacoub, Patrice P., Sr.
    Cantagrel, Alain G.
    Combe, Bernard
    Dougados, Maxime
    Flipo, Rene-Marc
    Godeau, Bertrand
    Guillevin, Loic
    Le Loet, Xavier X.
    Hachulla, Eric
    Schaeverbeke, Thierry
    Sibilia, Jean
    Pane, Isabelle
    Baron, Gabriel
    Mariette, Xavier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S561 - S562
  • [47] COST-EFFECTIVENESS ANALYSIS OF TWO RITUXIMAB BASED THERAPEUTIC REGIMENS FOR LONGSTANDING RHEUMATOID ARTHRITIS
    Quartuccio, L.
    Di Bidino, R.
    Ruggeri, M.
    Biasi, D.
    Adami, S.
    Schiavon, F.
    Punzi, L.
    Cicchetti, A.
    De Vita, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 563 - 563
  • [48] Early Versus Delayed Retreatment with Rituximab (RTX) in Relation to Long Term Clinical Response-Data From the CERERRA Collaboration.
    Lie, Elisabeth
    Chatzidionysiou, Katerina
    Nasonov, Evgeny L.
    Lukina, Galina
    Pavelka, Karel
    Nordstrom, Dan C.
    Tomsic, Matija
    Gabay, Cem
    Ancuta, Ioan
    van Riel, Piet L. C.
    Gomez-Reino, Juan J.
    Fonseca, Joao E.
    Hetland, Merete L.
    Tarp, Ulrik
    van Vollenhoven, Ronald F.
    Kvien, Tore K.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S169 - S170
  • [49] Effectiveness of TNF inhibitor treatment with various methotrexate doses in patients with rheumatoid arthritis: results from clinical practice
    Manders, Sofie H. M.
    Kievit, Wietske
    Adang, Eddy
    Jansen, Tim J.
    Stolk, Jan N.
    Visser, Henk
    Schilder, Annemarie M.
    Vonkeman, Harald E.
    van de Laar, Mart A. F. J.
    van Riel, Piet L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03)
  • [50] EFFICACY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH BRONCHIECTASIS: RESULTS FROM A MULTICENTRE COHORT
    Iqbal, Kundan
    Yuzaiful, Md Yusof Md
    Emery, Paul
    Dass, Shouvik
    Kelly, Clive
    RHEUMATOLOGY, 2016, 55 : 104 - 104
12345